Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | WDR5 | P61964 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4417719 | 0.87 | MEN1 (0.60) | KMT2AMEN1MAPTKDM4ELMNA | |
| Hydrochloric Acid SCHEMBL4422818 | 0.85 | MEN1 (0.59) | KMT2AMEN1MAPTKDM4ELMNA | |
| SCHEMBL29499501 | 0.74 | MEN1 (1.00) | KMT2AMEN1MAPTKDM4ELMNA | |
| SCHEMBL31583 | 0.74 | MEN1 (1.00) | KMT2AMEN1MAPTKDM4ELMNA | |
| Iodide SCHEMBL29456898 | 0.73 | MEN1 (0.97) | KMT2AMEN1MAPTKDM4ELMNA | |
| Iodide SCHEMBL22542621 | 0.73 | MEN1 (0.97) | KMT2AMEN1MAPTKDM4ELMNA | |
| Hydrochloric Acid SCHEMBL22321960 | 0.73 | MEN1 (0.97) | KMT2AMEN1MAPTKDM4ELMNA | |
| SCHEMBL21795198 | 0.71 | MEN1 (0.64) | KMT2AMEN1MAPTKDM4ELMNA | |
| SCHEMBL11947486 | 0.71 | MEN1 (0.64) | KMT2AMEN1MAPTKDM4ELMNA | |
| SCHEMBL4415820 | 0.70 | MEN1 (0.62) | KMT2AMEN1MAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | disclosed |
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | disclosed |
| US-7262306-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-7262306-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20060199223-A1 | storage stability; immunoassays | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| EP-1646609-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | Roche Diagnostics GmbH (DE) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005005385-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1496050-A1 | Novel chemiluminescent compounds and their use | Roche Diagnostics GmbH (DE) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199223-A1 | storage stability; immunoassays | SHBG, SELL, XIAP | KMT2A 4213/4885MEN1 2683/4885MAPT 1849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.